Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

The skin is a large organ that plays a role in the immune system.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

The study suggests silicon might be important for healthy hair, as less silicon was found in people with hair loss.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

SLHA can be hard to diagnose and needs teamwork between specialists.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Fetal skin has unique immune cells different from adult skin.